Rehab M Abdel-Megeed
Overview
    Explore the profile of Rehab M Abdel-Megeed including associated specialties, affiliations and a list of published articles.
          
  Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
  
  
  Snapshot
          Snapshot
              Articles
              19
            
            
              Citations
              79
            
            
              Followers
              0
            
  
  Related Specialties
          Related Specialties
  Top 10 Co-Authors
          Top 10 Co-Authors
  Published In
          
        
        
        
  Affiliations
        Affiliations
    Soon will be listed here.
  
  Recent Articles
          1.
        
    
    Kadry M, Abd-Ellatef G, Ammar N, Hassan H, Hussein N, Kamel N, et al.
  
  
    Toxicol Rep
    . 2025 Jan;
          14:101884.
    
    PMID: 39886047
  
  
          Resistance of cancer cells, especially breast cancer, to therapeutic medicines represents a major clinical obstacle that impedes the stages of treatment. Carcinoma cells that acquire resistance to therapeutic drugs can...
      
2.
        
    
    Abdel-Megeed R
  
  
    Toxicol Rep
    . 2025 Jan;
          14:101887.
    
    PMID: 39867515
  
  
          Nanotechnology has significantly influenced the worldwide medical services sector during the past few decades. Biological collection approaches for nanoparticles are economical, non-toxic, and ecologically benign. This review provides up-to-date information...
      
3.
        
    
    Abdel-Megeed R, Abdel-Hamid A, Kadry M
  
  
    Toxicol Rep
    . 2025 Jan;
          14():101869.
    
    PMID: 39811821
  
  
          Doxorubicin (DOX) is a powerful antineoplastic FDA-approved anthracycline-derived antibiotic and is considered as the most suitable intervention for solid tumors and hematological cancers therapy. However, its therapeutic application is highly...
      
4.
        
    
    Kadry M, Abdel-Megeed R
  
  
    Toxicol Rep
    . 2024 Nov;
          13:101807.
    
    PMID: 39606774
  
  
          Necroptosis is an innovative class of programmed autophagy (Atg) and necrosis; considered as a type of homeostatic housekeeping machinery that have observed an escalating concern due to its power in...
      
5.
        
    
    Kadry M, Abdel-Megeed R
  
  
    Future Sci OA
    . 2024 Nov;
          10(1):2422791.
    
    PMID: 39584686
  
  
           Endoplasmic reticulum stress triggers neuronal unfolded protein accumulation, contributing to the pathophysiology of depression psychiatric illnesses. The brain-derived neurotrophic factor (), metabotropic glutamate receptor type 7 (), phosphoinisitol kinase-3 (),...
      
6.
        
    
    Kadry M, Abdel Hamid A, Abdel-Megeed R
  
  
    Future Sci OA
    . 2024 Jun;
          10(1):FSO934.
    
    PMID: 38827790
  
  
           Leukemia is a malignant clonal illness stem from the mutations of hematopoietic cells. Acute lymphoblastic leukemia is one of the utmost prevalent kinds of leukemia, is brought on by atypical...
      
7.
        
    
    Abdel-Megeed R, Abdel-Hamid A, Kadry M
  
  
    Future Sci OA
    . 2024 Jun;
          10(1):FSO979.
    
    PMID: 38827789
  
  
           To clarify the alternation of gene expression responsible for resistance of Adriamycin (ADR) in rats, in addition to investigation of a novel promising drug-delivery system using titanium dioxide nanoparticles loaded...
      
8.
        
    
    Kadry M, Abdel-Megeed R
  
  
    PLoS One
    . 2024 May;
          19(5):e0302264.
    
    PMID: 38723038
  
  
          CRISPR/Cas9 is a recently discovered genomic editing technique that altered scientist's sight in studying genes function. Cas9 is controlled via guide (g) RNAs, which match the DNA targeted in cleavage...
      
9.
        
    
    Abdel-Megeed R, Ghanem H, Kadry M
  
  
    Ther Deliv
    . 2024 Apr;
          15(6):413-426.
    
    PMID: 38639647
  
  
           Drug resistance is still a significant barrier to effective hepatocellular carcinoma therapy. Address the issue of doxorubicin resistance and inter-receptor crosstalk various doxorubicin formulations were investigated.  Hepatocellular carcinoma was carried...
      
10.
        
    
    Abdel-Megeed R, Kadry M
  
  
    Heliyon
    . 2023 May;
          9(5):e15692.
    
    PMID: 37139293
  
  
          Lipopolysaccharide (LPS) has previously been implicated in insulin resistance by generating an innate immune response and activating inflammatory cascades. Many studies have discovered a relationship between high levels of serum...